semaglutide frequent urination and UTI: does GLP-1 therapy increase urinary tract infection risk? Rybelsus: Side Effects and How

The vast majority of UK patients pay for their medications privately and prescriptions can cost more than 300 a month

The Dutch-language version was written by Christophe Stove, PharmD, PhD, University of Ghent, Belgium

Clinical Evidence on GLP-1 and Heart Rate Changes Major clinical trials evaluating semaglutide and tirzepatide documented heart rate increases in subgroups of participants

Healthcare The combination of obesitys prevalence and its potential negative impact on patients means that any significant change in the trajectory for these patients can lead to a fundamental shift in the healthcare products and services needed in this country

A more recent study, published in 2024 by H

Lab work and baseline monitoring